These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15087285)

  • 21. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
    Laufs U; La Fata V; Plutzky J; Liao JK
    Circulation; 1998 Mar; 97(12):1129-35. PubMed ID: 9537338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells.
    Uruno A; Sugawara A; Kanatsuka H; Arima S; Taniyama Y; Kudo M; Takeuchi K; Ito S
    Hypertens Res; 2004 Nov; 27(11):887-95. PubMed ID: 15824471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.
    Merla R; Ye Y; Lin Y; Manickavasagam S; Huang MH; Perez-Polo RJ; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1918-28. PubMed ID: 17616749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
    Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
    Br J Pharmacol; 2007 Feb; 150(4):470-9. PubMed ID: 17220911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.
    Laufs U; Liao JK
    J Biol Chem; 1998 Sep; 273(37):24266-71. PubMed ID: 9727051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
    Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
    Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases.
    Ning WH; Zhao K
    Vascul Pharmacol; 2013; 59(3-4):76-82. PubMed ID: 23850990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase.
    Michell BJ; Chen Zp ; Tiganis T; Stapleton D; Katsis F; Power DA; Sim AT; Kemp BE
    J Biol Chem; 2001 May; 276(21):17625-8. PubMed ID: 11292821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide.
    Cai H; Li Z; Davis ME; Kanner W; Harrison DG; Dudley SC
    Mol Pharmacol; 2003 Feb; 63(2):325-31. PubMed ID: 12527803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of endothelial nitric oxide synthase by cyanidin-3-glucoside, a typical anthocyanin pigment.
    Xu JW; Ikeda K; Yamori Y
    Hypertension; 2004 Aug; 44(2):217-22. PubMed ID: 15226277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telmisartan Inhibits Nitric Oxide Production and Vessel Relaxation via Protein Phosphatase 2A-mediated Endothelial NO Synthase-Ser
    Cho DH
    J Korean Med Sci; 2019 Nov; 34(42):e266. PubMed ID: 31674157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.
    Fleming I; Fisslthaler B; Dimmeler S; Kemp BE; Busse R
    Circ Res; 2001 Jun; 88(11):E68-75. PubMed ID: 11397791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.
    Gao F; Gao E; Yue TL; Ohlstein EH; Lopez BL; Christopher TA; Ma XL
    Circulation; 2002 Mar; 105(12):1497-502. PubMed ID: 11914261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysophosphatidic acid and receptor-mediated activation of endothelial nitric-oxide synthase.
    Kou R; Igarashi J; Michel T
    Biochemistry; 2002 Apr; 41(15):4982-8. PubMed ID: 11939794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
    Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
    Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport.
    Li C; Huang W; Harris MB; Goolsby JM; Venema RC
    Biochem J; 2005 Mar; 386(Pt 3):567-74. PubMed ID: 15743275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.